United States - Re-Export of Antisera and Other Blood Fractions
Since 2014, United States Re-Export of Antisera and Other Blood Fractions jumped by 3.9% year on year. In 2019, the country was number 1 among other countries in Re-Export of Antisera and Other Blood Fractions at $614,613,635.05. Italy, Canada and United Arab Emirates respectively ranked number 2, 3 and 4 in this ranking. United Arab Emirates witnessed the best average annual growth at +80.6% per year, while Oman witnessed the worst performance at -61.8% per year.
| Date | US Dollars |
|---|---|
| 2019 | 614,613,635.05 |
| 2018 | 580,517,250.39 |
| 2017 | 545,725,021.14 |
| 2016 | 493,297,984.00 |
| 2015 | 519,473,536.00 |
Download all data from 1991 to 2019
How does United States rank in Re-Export of Antisera and Other Blood Fractions?
| # | 16 Countries | US Dollars | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
614,613,635.05 | 2019 | +5.9 % | +3.9 % | View data |
| 2 |
#2
Italy
|
509,690,540.30 | 2019 | +7.1 % | +21.3 % | View data |
| 3 |
#3
Canada
|
7,520,819.00 | 2016 | -58.5 % | -53.0 % | View data |
| 4 |
#4
United Arab Emirates
|
2,221,861.26 | 2019 | -24.5 % | +80.6 % | View data |
| 5 |
#5
Jordan
|
1,132,890.00 | 2019 | +3.2 % | +29.7 % | View data |